Triple Cardiovascular Disease Detection With an Artificial Intelligence-enabled Stethoscope

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 200 participants.

Also called NCT05987670

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05987670
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05987670. Randomized; no masking; primary purpose diagnostic. Start 2023-10-25 (actual); primary completion 2028-06-23 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Triple Cardiovascular Disease Detection With an Artificial Intelligence-enabled Stethoscope
Acronym
TRICORDER
Condition
Heart Failure
Condition
Heart Valve Diseases
Condition
Heart Murmurs
Condition
Congestive Heart Failure
Intervention (Device)
AI-stethoscope
Lead sponsor
Imperial College London (class: other)
Collaborator
Imperial College Health Partners (ICHP) (class: other)

Record details

Record id
cardio:ct-nct05987670
Content hash
4c301545cd55bd1a2e0e42e67b92c81c10a248adb2d2b2fb269374c02e69a99d